Selenium-based pharmacological agents: An update

Expert Opinion on Investigational Drugs

Volumn 11, Issue 9, 2002, Pages 1261-1269

  May, Sheldon W ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Antihypertensives; Antioxidants; Antitumour agents; IMPDH inhibitors; Phenylaminoalkyl selenides; Selenium; Selenium metabolites; Thioredoxin reductase

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; AURANOFIN; AUROTHIOGLUCOSE; CISPLATIN; DOPAMINE BETA MONOOXYGENASE; DOXORUBICIN; EBSELEN; FREE RADICAL; GLUTATHIONE PEROXIDASE; HYDRALAZINE; INOSINATE DEHYDROGENASE; INOSINATE DEHYDROGENASE INHIBITOR; MELPHALAN; MYCOPHENOLIC ACID; ORGANOSELENIUM DERIVATIVE; OXIDOREDUCTASE INHIBITOR; PACLITAXEL; PHENYLAMINOALKYL SELENIDE DERIVATIVE; SELENAZOFURIN; SELENITE; SELENIUM DERIVATIVE; SELENOBETAINE; SELENOCYSTAMINE; SELENODIGLUTATHIONE; SELENOMETHIONINE; SELENOPROTEIN; THIOREDOXIN REDUCTASE; TIAZOFURIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIHYPERTENSIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER; CELL PROTECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME MECHANISM; HUMAN; MOUSE; NONHUMAN; OXIDATIVE STRESS; RAT; REVIEW; RISK FACTOR;

ANIMALS; HUMANS; PHARMACEUTICAL PREPARATIONS; SELENIUM COMPOUNDS;

EID: 0036739735     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.11.9.1261     Document Type: Review

References (69)

1. Can selenoamino acids act as reversible biological antioxidants?
2. Dietary Supplements of vitamin E, b-carotene, coenzyme Q10, and selenium protect tissues against lipid peroxidation in rat tissue slices
3. Reactions of seleno- and sulfoamino acids with hydroperoxides
4. Selenomethionine as an antioxidant
5. The role of selenium in nutrition
6. Mechanisms of selenium inhibition of tumorigenesis
7. Lessons from basic research in selenium and cancer prevention
8. Selenium in carcinogenesis
9. Anticarcinogenic effects of selenium
10. Effect of selenium Supplementation for cancer prevention in patients with carcinoma of the skin
11. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer
12. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase
13. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines
14. Selenium and cardiovascular diseases-an update
15. Plasma selenium levels in rheumatoid arthritis
16. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions
17. Selenium: Nutritional implications and prospects for therapeutic medicine
18. High risk of HIV-related mortality is associated with selenium deficiency
19. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids
20. Selenium-based drug design: Rationale and therapeutic potential
21. Interacting Nutritional and infectious etiologies of Keshan disease. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E
22. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice
23. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates
24. Possible protective effect of selenium against human cancer
25. Interpretation of the methylene blue reduction test of human plasma and the possible cancer protecting effect of selenium
26. Selenium in forage crops and cancer mortality in US counties
27. Studies on human dietary requirements and safe range of dietary intakes of selenium in China and their application in the prevention of related endemic diseases
28. Naturally occurring selenium compounds in cancer chemoprevention trials: A workshop summary
29. Selenium in soil and endemic diseases in China
30. Ascorbate depletion as a consequence of product recycling during dopamine b-monooxygenase catalyzed selenoxidation
31. Novel antihypertensives targeted at dopamine b-monooxygenase: Turnover-dependent cofactor depletion by phenyl aminoethyl selenide
32. Effects of dopamine b-monooxygenase substrate analogs on ascorbate levels and norepinephrine synthesis in adrenal chromaffin granule ghosts
33. Demonstration of the ascorbate dependence of membrane-bound dopamine b-monooxygenase in adrenal chromaffin granule ghosts
34. Demonstration of the antihypertensive activity of phenyl-2-aminoethyl selenide
35. An orally active selenium-based antihypertensive agent with restricted CNS permeability
36. Evaluation of Cardiovascular Parameters of a Selenium-Based Antihypertensive Using Pulsed Doppler Ultrasound
37. The pharmaceutical potential of selenium
38. Ebselen in acute ischemic stroke: A placebo-controlled, double-blind clinical trial
39. Ebselen prevents early alcohol-induced liver injury in rats
40. The Antioxidant Ebselen Prevents Neurotoxicity and Clinical Symptoms in a Primate Model of Parkinson's disease
41. Acid-volatile selenium formation catalyzed by glutathione reductase
42. Selenotrisulfides: Formation by the reaction of thiols with selenious acid
43. The selenium metabolite selenodiglutathione induces p53 and apoptosis: Relevance to the chemopreventive effects of selenium?
44. Comparison of selenium and sulfur analogs in cancer prevention
45. Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione
46. AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione
47. The effects of topical and oral L-selenomethionine on pigmentation and skin cancer induced by ultraviolet irradiation
48. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines
49. Chemopreventive Agents: Selenium
50. Chemopreventive mechanisms of selenium
51. A prevention strategy for circumventing drug resistance in cancer chemotherapy
52. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells
53. Ascorbic acid mediated N-dealkylation and N-deoxygenation of N,N-dimethylaniline N-oxide
54. A new selenoprotein from human lung adenocarcinoma cells: Purification, properties, and thioredoxin reductase activity
55. The biochemistry of selenium and the glutathione system
56. Oxidants, antioxidants, and the degenerative diseases of aging
57. Reaction of phenylaminoethyl selenides with peroxynitrite and hydrogen peroxide
58. Selenium and the thioredoxin and glutaredoxin systems
59. The thioredoxin/thioredoxin reductase redox system and control of cell growth
60. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism
61. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism
62. Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells
63. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents
64. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds
65. Aurothioglucose inhibits murine thioredoxin reductase activity in vivo
66. Cytotoxicity and cellular differentiation activity of methylenebis(phosphonate) analogs of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell lines
67. Studies on the Mechanism of Action of Benzamide Riboside A Novel Inhibitor of IMP Dehydrogenase
68. Speciation and Identification of Organo-Selenium Metabolites in Human Urine Using Inductively Coupled Plasma/Mass Spectrometry and Tandem Mass Spectrometry